NDC 65219-371

Stimufend 6 mg per 0.6 mL injection, solution

On the label: Fresenius Kabi USA, LLC.

United Kingdom: 1United States: 1Italy: 1

Where it's made

FactoryWhereRoleLast FDA inspection
FUJIFILM Diosynth Biotechnologies UK LtdBillingham, United KingdomMakes the active ingredient and tests it Problems found, fixed voluntarilyMar 17, 2023 · 6 inspections
Fresenius Kabi USA, LLCWilson, NC, United StatesMakes it and tests it Problems found, fixed voluntarilyFeb 13, 2026 · 5 inspections
Merck Biodevelopment, MartillacLocation not on fileMakes the active ingredient and tests it Not inspected on record
Merck Serono SpaModugno (loc. frazione Zona Industriale), ItalyMakes it Problems found, fixed voluntarilySep 26, 2025 · 9 inspections
Fresenius Kabi AustriaAustria 8055, AustriaPackages it Problems found, fixed voluntarilyMar 21, 2024 · 9 inspections
Istituto Di Ricerche Biomediche Antoine Marxer RBM SpAColleretto Giacosa, ItalyTests it Problems found, fixed voluntarilyJul 12, 2024 · 5 inspections
Merck Serono SpaGuidonia Montecelio, ItalyTests it Problems found, fixed voluntarilyJul 11, 2024 · 7 inspections, 1 with FDA action

Product details

Generic drug
Pegfilgrastim: every company that makes it
Form
injection, solution, subcutaneous
Strength
6 mg per 0.6 mL
Approval
BLA BLA761173
On the market since
Oct 6, 2022
Package NDCs
65219-371-10
Official label
DailyMed (National Library of Medicine), updated Oct 24, 2023

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?